Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a site deployment update. No study content or data appear to have changed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s footer version label was updated from one revision number to the next (v3.5.2 → v3.5.3), reflecting a site/display revision rather than any changes to the clinical trial record.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.5.2 replaces the previous v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Rhabdomyosarcoma as a focus term and included Genetic and Rare Diseases Information Center as a Resources link. Updated page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This appears to be a minor site maintenance update with no changes to study details or visible features.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated to v3.4.2. The prior funding-status notice and revision v3.4.1 were removed.SummaryDifference0.4%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.